Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/105416
Title: Reducing oral corticosteroids in severe asthma (ROSA Project): a nationwide Portuguese consensus
Authors: Loureiro, Cláudia Chaves 
Branco Ferreira, Manuel
Ferreira, Jorge
Lima, Ricardo 
Marques, João
Sokolova, Anna
Tonin, Fernanda S.
Duarte Ramos, Filipa
Keywords: Asthma; Oral corticosteroids; Delphi panel; Consensus
Issue Date: 2021
Publisher: Elsevier Espana S.L.U
Project: AstraZeneca 
Serial title, monograph or event: Pulmonology
Volume: 27
Issue: 4
Abstract: Introduction and objectives: We aimed to build a national consensus to optimize the use of oral corticosteroids (OCS) in severe asthma in Portugal. Material and methods: A modified 3-round Delphi including 65 statements (topics on chronic systemic corticotherapy, therapeutic schemes, asthma safety and monitoring) was performed via online platform (October-November 2019). A five-point Likert-type scale was used (1- ‘strongly disagree’; 5-‘strongly agree’). Consensus threshold was established as a percentage of agreement among participants ≥90% in the 1st round and ≥85% in the 2nd and 3rd rounds. The level of consensus achieved by the panel was discussed with the participants (face-to-face meeting). Results: Forty-eight expert physicians in severe asthma (specialists in allergology and pulmonology) participated in the study. Almost half of the statements (28/65; 43.1%) obtained positive consensus by the end of round one. By the end of the exercise, 12 (18.5%) statements did not achieve consensus. Overall, 87% of physicians agree that further actions for OCS cumu-lative risk assessment in acute asthma exacerbations are needed. The vast majority (91.7%)demonstrated a favorable perception for using biological agents whenever patients are eligible.Most participants (95.8%) are more willing to accept some degree of lung function deteriorationcompared to other outcomes (worsening of symptoms, quality of life) when reducing OCS dose.Monitoring patients’ comorbidities was rated as imperative by all experts.Conclusions: : These results can guide an update on asthma management in Portugal and shouldbe supplemented by studies on therapy access, patients’ adherence, and costs.
URI: https://hdl.handle.net/10316/105416
ISSN: 25310437
DOI: 10.1016/j.pulmoe.2020.10.002
Rights: openAccess
Appears in Collections:FMUC Medicina - Artigos em Revistas Internacionais

Files in This Item:
File Description SizeFormat
1-s2.0-S2531043720302178-main.pdf750.05 kBAdobe PDFView/Open
Show full item record

SCOPUSTM   
Citations

6
checked on Feb 19, 2024

WEB OF SCIENCETM
Citations

4
checked on Feb 2, 2024

Page view(s)

24
checked on Feb 20, 2024

Download(s)

15
checked on Feb 20, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons